Improvements to the HITS-CLIP protocol eliminate widespread mispriming artifacts

por Gillen, Austin E., Yamamoto, Tomomi M., Kline, Enos, Hesselberth, Jay R., Kabos, Peter
Publicado 2016

Transcription factor–nucleosome dynamics from plasma cfDNA identifies ER-driven states in breast cancer

por Rao, Satyanarayan, Han, Amy L., Zukowski, Alexis, Kopin, Etana, Sartorius, Carol A., Kabos, Peter, Ramachandran, Srinivas
Publicado 2022

Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval

por Stoen, Ericson, Kagihara, Jodi, Shagisultanova, Elena, Fisher, Christine M., Nicklawsky, Andrew, Kabos, Peter, Borges, Virginia F., Diamond, Jennifer R.
Publicado 2021

BSCI-18 ESTROGEN-DEPLETION DECREASES PROGRESSION OF ER¯ BRAIN METASTASES BY PROMOTING AN ANTI-TUMORAL LOCAL IMMUNE RESPONSE

por Contreras-Zarate, Maria, Alvarez-Eraso, Karen, Littrell, Zachary, Tsuji, Nicole, Karam, Sana, Ormond, D Ryan, Kabos, Peter, Cittelly, Diana
Publicado 2022

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer

por Dwyer, Amy R., Truong, Thu H., Kerkvliet, Carlos Perez, Paul, Kiran V., Kabos, Peter, Sartorius, Carol A., Lange, Carol A.
Publicado 2020

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery

por Reid, Brian G., Jerjian, Taleen, Patel, Purvi, Zhou, Qiong, Yoo, Byong Hoon, Kabos, Peter, Sartorius, Carol A., LaBarbera, Daniel V.
Publicado 2014

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

por Finlay-Schultz, Jessica, Cittelly, Diana M., Hendricks, Peter, Patel, Purvi, Kabos, Peter, Jacobsen, Britta M., Richer, Jennifer K., Sartorius, Carol A.
Publicado 2014

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials

por Schreiber, Anna R., Kagihara, Jodi A., Weiss, Jennifer A., Nicklawsky, Andrew, Gao, Dexiang, Borges, Virginia F., Kabos, Peter, Diamond, Jennifer R.
Publicado 2021

Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2

por Shagisultanova, Elena, Crump, Lyndsey S., Borakove, Michelle, Hall, Jessica K., Rasti, Aryana R., Harrison, Benjamin A., Kabos, Peter, Lyons, Traci R., Borges, Virginia F.
Publicado 2022

Cytokeratin 5 alters β-catenin dynamics in breast cancer cells

por McGinn, Olivia, Ward, Ashley V., Fettig, Lynsey M., Riley, Duncan, Ivie, Joshua, Paul, Kiran V., Kabos, Peter, Finlay-Schultz, Jessica, Sartorius, Carol A.
Publicado 2020

New generation breast cancer cell lines developed from patient-derived xenografts

por Finlay-Schultz, Jessica, Jacobsen, Britta M., Riley, Duncan, Paul, Kiran V., Turner, Scott, Ferreira-Gonzalez, Andrea, Harrell, J. Chuck, Kabos, Peter, Sartorius, Carol A.
Publicado 2020

Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study

por Schreiber, Anna R., Kagihara, Jodi, Eguchi, Megan, Kabos, Peter, Fisher, Christine M., Meyer, Elisabeth, Molina, Elizabeth, Kondapalli, Lavanya, Bradley, Cathy J., Diamond, Jennifer R.
Publicado 2021

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and tra...

por Iwanaga, Ritsuko, Wang, Chu-An, Micalizzi, Douglas S, Harrell, J Chuck, Jedlicka, Paul, Sartorius, Carol A, Kabos, Peter, Farabaugh, Susan M, Bradford, Andrew P, Ford, Heide L
Publicado 2012

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism

por Ward, Ashley V., Matthews, Shawna B., Fettig, Lynsey M., Riley, Duncan, Finlay-Schultz, Jessica, Paul, Kiran V., Jackman, Matthew, Kabos, Peter, MacLean, Paul S., Sartorius, Carol A.
Publicado 2022

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

por Sartorius, Carol A., Hanna, Colton T., Gril, Brunilde, Cruz, Hazel, Serkova, Natalie J., Huber, Kendra M., Kabos, Peter, Schedin, Troy B., Borges, Virginia F., Steeg, Patricia S., Cittelly, Diana M.
Publicado 2015

Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries

por Riemondy, Kent A, Ransom, Monica, Alderman, Christopher, Gillen, Austin E, Fu, Rui, Finlay-Schultz, Jessica, Kirkpatrick, Gregory D, Di Paola, Jorge, Kabos, Peter, Sartorius, Carol A, Hesselberth, Jay R
Publicado 2019

Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center

por Weiss, Jennifer A., Nicklawsky, Andrew, Kagihara, Jodi A., Gao, Dexiang, Fisher, Christine, Elias, Anthony, Borges, Virginia F., Kabos, Peter, Davis, Sarah L., Leong, Stephen, Eckhardt, Sue Gail, Diamond, Jennifer R.
Publicado 2020

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer

por Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G., Wang, Yamei, Conlan, Maureen G., Kabos, Peter
Publicado 2021

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

por Rugo, Hope S., Kabos, Peter, Beck, J. Thad, Jerusalem, Guy, Wildiers, Hans, Sevillano, Elena, Paz-Ares, Luis, Chisamore, Michael J., Chapman, Sonya C., Hossain, Anwar M., Chen, Yanyun, Tolaney, Sara M.
Publicado 2022

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Can...

por Ionkina, Anastasia A., Tentler, John J., Kim, Jihye, Capasso, Anna, Pitts, Todd M., Ryall, Karen A., Howison, Rebekah R., Kabos, Peter, Sartorius, Carol A., Tan, Aik Choon, Eckhardt, S. Gail, Diamond, Jennifer R.
Publicado 2017